GLP-1 Weight Loss Drugs Could Stop Cancer Progressing Says New Study

GLP-1 drugs commonly used for weight loss and diabetes decreased the risk of cancer spreading in patients with several different types of tumors including breast and lung

E-Cigarettes Can Help You Quit Smoking Says New Study

E-cigarettes containing nicotine can help people quit smoking according to a new study and may be more helpful for some smokers than other nicotine products like patches.

Second Trump Administration’s Pivot On Vaping Leads To Resignations

High level resignations in protest against the push to allow sales of fruit-flavored vapes suggest a break in policy between the first and second Trump administrations.

Unclear How FDA Commissioner Makary’s Departure Will Impact His Initiatives

During a tumultuous 13-month tenure at the FDA, Makary pursued a wide range of ambitious initiatives. Going forward, their status under the next commissioner is unclear.

Teaching Your Body To Make Designer Antibodies

Editing a small number of blood-forming stem cells to encode powerful antibodies turns the immune system into a living drug factory.

Gene Therapy May Finally Reach The Right Cells

Engineered exosomes that naturally go to brain and kidney cells can deliver gene‑silencing drugs far beyond the liver.

Internal Nanobodies Tackle Cystic Fibrosis

A nanobody that stabilizes mutant CFTR from inside the cell, especially when combined with existing drugs, restores near-normal function in cystic fibrosis cells.

Policy Of Auto-Enrolling Seniors In Medicare Advantage Could Backfire

Should Medicare change the default option for new beneficiaries to Medicare Advantage or an ACO, this could backfire as costs could rise and access restrictions increase.

Grandstanding In Congressional Hearings Doesn’t Solve Healthcare Problems

In Congress, hearings on healthcare tend to function as venues for adversarial political messaging and electoral gain rather than legislative consensus-building.

Questionable White House Math On Savings From Most Favored Nation Drug Prices

White House model estimates on cost savings from most-favored nation drug prices are speculative and depend on a set of unrealistic assumptions.